Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic skin disorders often experience depression, anxiety, and reduced quality of life and may benefit from psychiatric help.

Three new types of a skin blistering disease were found, caused by specific gene mutations.

Epidermolysis bullosa is a genetic disease causing fragile skin and blisters in both animals and humans.

The document suggests that certain protein deficiencies and scalp blistering in Epidermolysis Bullosa may cause hair loss.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

A rare gene mutation causes skin fragility and itching without affecting hair or nails.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

Colored hair-thickening fibers can help hide hair loss in some people with Epidermolysis Bullosa but may cause scalp irritation.

Skin cells from people with Epidermolysis Bullosa Simplex have abnormally placed and less active mitochondria.

Two patients with the same genetic mutation had both blistering skin and easily pulled out hair.

People with Epidermolysis bullosa have many health problems including poor oral health, which is often neglected due to other medical issues.

Middle Eastern patients with epidermolysis bullosa show specific genetic mutations linked to different types of the disease.

The specific skin disease variant p.(Arg2000Trp) in plectin can cause a wide range of symptoms, which should be considered when diagnosing patients.

Epidermolysis bullosa is an inherited condition causing fragile skin with no cure, managed by wound care and experimental treatments show promise.

Most Recessive Dystrophic Epidermolysis Bullosa patients with a specific mutation likely have Sephardic ancestry from about 500 years ago.

Henna ointment may help reduce itching and improve wound healing in patients with epidermolysis bullosa.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

A woman with lupus also developed a severe skin condition linked to a genetic factor.

Scientists used stem cells to create a model of the skin disease Epidermolysis Bullosa simplex, which helped them understand its molecular mechanisms and could aid in finding treatments.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

A new therapy for a skin blistering condition has not been developed yet.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

A Chinese male with a new genetic mutation has a skin condition and severe urinary issues, with treatments having mixed success.

The document concludes that detailed clinical descriptions of seven family cases help understand dominant dystrophic epidermolysis bullosa's symptoms and inheritance.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Genetic testing is crucial for diagnosing and managing non-Herlitz junctional epidermolysis bullosa.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.